Popular diabetes and weight loss medications like Ozempic and Wegovy have been linked with an increased risk of developing stomach paralysis, new studies have found.
(Freepik)Stomach paralysis, also know as gastroparesis, weakens the stomach muscles, leading to food sitting in the main digestive organ for long.
However, Ozempic is sometimes prescribed for weight loss, even though it is not FDA-approved for this purpose.
The second study assessed the risk of gastroparesis in patients with type 2 diabetes treated with GLP-1 receptor agonists (RA).
"Patients with T2D prescribed GLP-1 RAs had an increased risk of GP at 6, 9, 12, 18 and at 24 months.

Widely used diabetes and weight-loss medications linked with increased risk of stomach paralysis: Study